Analysis To Determine The Prostate Cancer Prevalence, Awareness, Knowledge, Uptake Of Screening, And Their Associations With Socio-Demographic Variables Among Men Of 40 Years And Above
– Analysis To Determine The Prostate Cancer Prevalence, Awareness, Knowledge, Uptake Of Screening, And Their Associations With Socio-Demographic Variables Among Men Of 40 Years And Above –
Download Analysis To Determine The Prostate Cancer Prevalence, Awareness, Knowledge, Uptake Of Screening, And Their Associations With Socio-Demographic Variables Among Men Of 40 Years And Above project materials: This project material is ready for students who are in need of it to aid their research.
INTRODUCTION
1.1. Background to the study
Prostate cancer (PC) is an adenocarcinoma of the male prostate gland. It is increasingly becoming an important health burden among men in the world (Ferlayet al., 2011; Lozano et al., 2012).
An estimated 0.9 million cases and 0.26 million deaths of prostate cancer occur annually in the world (Ferlayet al., 2011).
Prostate cancer is the number one cancer in both incidences and mortality in Africa, constituting 40,000 (13%) of all male cancer incidences and 28,000 (11.3%) of all male cancer-associated mortalities (Ferlayet al., 2011).
In East Africa, prostate cancer ranks third in both incidence and mortality, and leads to an estimated 9,000 (9% of all male cancers) cases and 7,300 (8.5% of all male cancer) deaths annually (Ferlayet al., 2011).
It is important to note that Prostate cancer incidences increased by 64.5% between 1990 and 2010 (Lozano et al., 2012).
Prostate is the tubuloalveolar exocrine gland of the male reproductive system. It is about 3cm long, weighs about 20g and is located in the pelvis, under the urinary bladder and in front of the rectum (Meyers and Robert, 2000).
The function of the prostate is to store and secrete a slightly alkaline fluid, milky or white in appearance, that usually constitutes 25-30% of the volume of the semen along with spermatozoa and seminal vesicle fluid (Babain et al., 1999).
REFERENCES
Abernethy, A. D., Houston, T. R., Bjorck, J. P., Gorsuch, R. L., & Arnold, H. L., Jr. (2009). Religiousness and prostate cancer screening in African American men.J PsychosocOncol, 27(3), 316-331.
Ajape, A. A., Babata, A., &Abiola, O. O. (2009).Knowledge of prostate cancer screening among native African urban population in Nigeria.Nig Q J Hosp Med, 19(3), 145-147.
Ajape, A. A., Ibrahim, K. O., Fakeye, J. A., &Abiola, O. O. (2010). An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital. Ann Afr Med, 9(3), 113-117.
Andriole, G. L., Crawford, E. D., Grubb, R. L., 3rd, Buys, S. S., Chia, D., Church, T. R., et al. (2009). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360(13), 1310-1319.
Angwafo, F. F., 3rd, Zaher, A., Befidi-Mengue, R., Wonkam, A., Takougang, I., Powell, I., et al. (2003).High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon.Prostate Cancer Prostatic Dis, 6(1), 34-38.
Arafa, M. A., Rabah, D. M., &Wahdan, I. H. (2012). Awareness of general public towards cancer prostate and screening practice in Arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev, 13(9), 4321-4326.
Arnold-Reed, D. E., Hince, D. A., Bulsara, M. K., Ngo, H., Eaton, M., Wright, A. R., et al. (2008).Knowledge and attitudes of men about prostate cancer.Med J Aust, 189(6), 312-314.
